Severe paediatric systemic lupus erythematosus nephritis-a single-centre experience

Nephrology Dialysis Transplantation

Volumn 25, Issue 2, 2010, Pages 457-463

  Hobbs, David J ^a   Barletta, Gina Marie ^a   Rajpal, Jurat S ^b   Rajpal, Miriam N ^b   Weismantel, David P ^a   Birmingham, James D ^c   Bunchman, Timothy E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c HELEN DEVOS CHILDREN S HOSPITAL   (United States)

Author keywords

Anticardiolipin antibody; Dialysis; Paediatrics; Systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; LUPUS ANTICOAGULANT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; THROMBOEMBOLISM; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADOLESCENT; ANTIBODIES, ANTICARDIOLIPIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LUPUS NEPHRITIS; MALE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 75649144414     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp481     Document Type: Article

References (41)

1. Hikari LD, Benseler SM, Tyrrell PN et al. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus Erythematosus: a longitudinal study. J Pediatr 2008; 152: 550-556
2. Tucker LB, Menon S, Schaller JG et al. Adult-and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995; 34: 866-872
3. Font F, Cervera R, Espinosa G et al. Systemic lupus Erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rhuem Dis 1998; 57: 456-459
4. Brunner HI, Gladman DD, Ibanez D et al. Difference in disease features between childhood-onset and adult-onset systemic lupus erythe-matous. Arthritis Rhuem 2008; 58: 556-562
5. Baqi N, Moazami S, Singh A et al. Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 1996; 7: 924-929
6. Korbet SM, Lewis EJ, Schwartz MM et al. Lupus Nephritis Collaborative Study Group. Factors predictive of outcome in severe lupus nephritis. Am J Kidney Dis 2000; 35: 904-914
7. Bakkaloglu A. Lupus nephropathy in children. Nephrol Dial Transplant 2001; 16(S6): 126-128
8. Bogdanovic R, Nikolic V, Pasic S et al. Lupus nephritis in childhood: a review of 53 patients followed at a single center. Pediatr Nephrol 2004; 19: 36-44
9. Niaudet P. Treatment of lupus nephritis children. Pediatr Nephrol 2000; 14: 158-166
10. Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onsetof systemic lupusErythemato-sus. N Engl J Med 2003; 349: 1526-1533
11. McCLain MT, Arbuckle MR, Heinlen LD et al. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum 2004; 50: 1226-1232
12. Moroni G, Ventura D, Riva P et al. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am J Kidney Dis 2004; 43: 28-36
13. 2-glycoprotein I antibodies in lupus nephritis. Rheumatology 2000; 39: 962-968
14. Massengill SF, HedrickC,Ayoub EMet al. Antiphospholipid antibodies in pediatric lupus nephritis. Am J Kidney Dis 1997; 29: 355-361
15. Levy DM, Massicotte MP, Harvey E et al. Thromboembolism in paediatric lupus patients. Lupus 2003; 12: 741-746
16. Schmugge M, Revel-Vilk S, Hiraki L et al. Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus. J Pedi-atr 2003; 143: 666-669
17. Galli M, Luciani D, Bertolini G et al. Lupus anticoagulants are tronger risk factors for thrombosis than anticardiolipin antibodies in the an-tiphospholipid syndrome: a systematic review of the literature. Blood 2003; 101: 1827-1832
18. Male C, Foulon D, Hoogendoorn H et al. Predictive value of persistent versus transient antiphospholipid antibody for the risk of thrombotic events in pediatric patients with systemic lupus Erythematosus. Blood 2005; 106: 4152-4158
19. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277
20. Hochberg MC. Updating the American College of heumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725
21. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 1996; 98(Pt 1): 649-658
22. Weening JJ, D'Agati VD, Schwartz MM et al. The classification of glomerulonephritis in systemic lupus Erythematosus revisited. J Am Soc Nephrol 2004; 15: 241-250
23. Harris EN, Gharavi AE, Patel SS et al. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 215-222
24. Naess IA, Christianse SC, Cannegierter SC et al. A prospective study of anticardiolipin antibodies as a risk fator for venous thrombosis in a general population (the HUNT study). J Thromb Haemost 2006; 4: 44-49
25. Schwartz GJ, Haycock GB, Edelmann CM et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259-263
26. Ginzler EM, Dooley MA, Aranow C et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005; 353: 2219-2228
27. Paredes A. Can mycophenolate mofetil substitute cyclophosphamide treatment of pediatric lupus nephritis? Pediatr Nephrol 2007; 22: 1077-1082
28. Austin HA 3rd, Klippel JH, Balow JE et al. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.N Engl J Med 1986; 314: 614-619
29. Lau KK, Jones DP, Hastings MC et al. Short-term outcomes of severe lupus nephritis in a cohort of predominantly African-American children. Pediatr Nephrol 2006; 21: 655-662
30. Emre S, Bilge I, Sirin A et al. Lupus nephritis in children: prognostic significance of clinicopathological findings. Nephron 2001; 87: 118-126
31. McCurdy DK, Lehman TJ, Bernstein B et al. Lupus nephritis: prognostic factors in children. Pediatrics 1992; 89: 240-246
32. Joseph RE, Radhakrishnan J, Appel GB. Antiphospholipid antibody syndrome and renal disease. Curr Opin Nephrol Hypertens 2001; 10: 175-181
33. Lee BS, Cho HY, Kim EJ et al. Clinical outcomes of childhood lupus nephritis: a single center's experience. Pediatr Nephrol 2007; 22: 222-231
34. Tincani A, Allegri F, Sanmarco M et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations-a cooperative project of the European Antiphospho-lipid Forum. Thromb Haemost 2001; 86: 575-583
35. Arnout J, Vermylen J. Current status and implication of autoimmune antiphospholipid antibodies in relation to thrombotic disease. J Thromb Haemost 2003; 1: 931-942
36. Zapitelli M, Duffy C, Bernard C et al. Clinicopathological study of the WHO classification in childhood lupus nephritis. Pediatr Nephrol 2004; 19: 503-510
37. Yang LY, Chen WP, Lin CY. Lupus nephritis in children-a review of 167 patients. Pediatrics 1994; 94: 335-340
38. Frampton G, Hicks J, Cameron JS. Significance of anti-phospholipid antibodies in patients with lupus nephritis. Kidney Int 1991; 39: 1225-1231
39. Ravelli A, Caporali R, Fuccia GD et al. Anticardiolipin antibodies in pediatric systemic lupus erythematosus. Arch Pediatr Adolesc Med 1994; 148: 398-402
40. Seaman DE, Londino AV, Kwoh CK et al. Antiphospholipid antibodies in pediatric systemic lupus erythematosus. Pediatrics 1995; 96: 1040-1045
41. Tejani A, Nicastri AD, Chen CK et al. Lupus nephritis in black and Hispanic children. Am J Dis Child 1983; 137: 481-483